2-(Methoxycarbonylamino)buttersaeure-methylester | 21298-40-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(Methoxycarbonylamino)buttersaeure-methylester
• 英文别名: Methyl 2-(methoxycarbonylamino)butanoate；methyl 2-(methoxycarbonylamino)butanoate
• CAS: 21298-40-8
• 化学式: C₇H₁₃NO₄
• 分子量: 175.185
• InChiKey: UAQSGPUFHBLJSW-UHFFFAOYSA-N

物化性质

• 沸点：
  256.5±23.0 °C(Predicted)
• 密度：
  1.093±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  64.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(Methoxycarbonylamino)buttersaeure-methylester 在 盐酸 、 N,N-二甲基丙烯基脲 、 sodium hydride 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 水 、 甲苯 、 mineral oil 为溶剂， 反应 21.75h， 生成 methyl 2-ethyl-2-(3-fluorobenzyl)-3-oxopyrrolidine-1-carboxylate
  参考文献：
  名称：

  Novel tricyclic pyrazolopyrimidines as potent and selective GPR119 agonists

  摘要：

  Systematic SAR optimization of the GPR119 agonist lead 1, derived from an internal HTS campaign, led to compound 29. Compound 29 displays significantly improved in vitro activity and oral exposure, leading to GLP1 elevation in acutely dosed mice and reduced glucose excursion in an OGTT study in rats at doses >= 10 mg/kg. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2014.10.010
• 作为产物：
  描述：

  甲醇 、 potassium cyanate 、 methyl 2-chlorobutanoate 以 N,N-二甲基甲酰胺 为溶剂， 反应 30.0h， 以67%的产率得到2-(Methoxycarbonylamino)buttersaeure-methylester
  参考文献：
  名称：

  Effenberger, Franz; Drauz, Karlheinz; Foerster, Siegfried, Chemische Berichte, 1981, vol. 114, # 1, p. 173 - 189

  摘要：

  DOI：

文献信息

• Bis-(Alpha-Amino)-Diol-Diester-Containing Poly (Ester Amide) and Poly (Ester Urethane) Compositions and Methods of Use
  申请人：Gomurashvili Zaza D.

  公开号：US20080299174A1

  公开（公告）日：2008-12-04

  The present invention provides biodegradable, biocompatible bis-(α-amino acyl)-diol-diester-containing poly(ester amide) (PEA) and poly(ester urethane) (PEUR) co-polymer compositions with mechanical properties that can be readily tailored by selection of various combinations and proportions of the building blocks of the co-polymers. The compositions are suitable for use in production of drug-releasing biodegradable particles and implantable surgical devices, such as stents and internal fixation devices. The co-polymer compositions, particles and surgical devices biodegrade in vivo by enzymatic action to release bioactive agents in a controlled manner over time as well as biocompatible breakdown products, including one to multiple different amino acids.
• BIS-(ALPHA-AMINO)-DIOL-DIESTER-CONTAINING POLY (ESTER AMIDE) AND POLY (ESTER URETHANE) COMPOSITIONS AND METHODS OF USE
  申请人：MEDIVAS, LLC

  公开号：US20130210931A1

  公开（公告）日：2013-08-15

  The present invention provides biodegradable, biocompatible bis-(α-amino acyl)-diol-diester-containing poly(ester amide) (PEA) and poly(ester urethane) (PEUR) co-polymer compositions with mechanical properties that can be readily tailored by selection of various combinations and proportions of the building blocks of the co-polymers. The compositions are suitable for use in production of drug-releasing biodegradable particles and implantable surgical devices, such as stents and internal fixation devices. The co-polymer compositions, particles and surgical devices biodegrade in vivo by enzymatic action to release bioactive agents in a controlled manner over time as well as biocompatible breakdown products, including one to multiple different amino acids.
• US9102830B2
  申请人：——

  公开号：US9102830B2

  公开（公告）日：2015-08-11
• Novel tricyclic pyrazolopyrimidines as potent and selective GPR119 agonists
  作者：Mihai Azimioara、Phil Alper、Christopher Cow、Daniel Mutnick、Victor Nikulin、Gerald Lelais、John Mecom、Matthew McNeill、Pierre-Yves Michellys、Zhiliang Wang、Esther Reding、Michael Paliotti、Jing Li、Dingjiu Bao、Jocelyn Zoll、Young Kim、Matthew Zimmerman、Todd Groessl、Tove Tuntland、Sean B. Joseph、Peter McNamara、H. Martin Seidel、Robert Epple

  DOI：10.1016/j.bmcl.2014.10.010

  日期：2014.12

  Systematic SAR optimization of the GPR119 agonist lead 1, derived from an internal HTS campaign, led to compound 29. Compound 29 displays significantly improved in vitro activity and oral exposure, leading to GLP1 elevation in acutely dosed mice and reduced glucose excursion in an OGTT study in rats at doses >= 10 mg/kg. (C) 2014 Elsevier Ltd. All rights reserved.
• Effenberger, Franz; Drauz, Karlheinz; Foerster, Siegfried, Chemische Berichte, 1981, vol. 114, # 1, p. 173 - 189
  作者：Effenberger, Franz、Drauz, Karlheinz、Foerster, Siegfried、Mueller, Wolfgang

  DOI：——

  日期：——